# Mr. Aaron Hackman — Hazardous Materials Safety Interpretation

**Citation:** 11-0261  
**Type / status:** guidance / guidance  
**Agency:** Pipeline and Hazardous Materials Safety Administration  
**Effective:** Not stated  
**Published:** 2012-01-26

11-0261 concerning 172.312, 172.323, 173.134, 173.197, 173.24.

## Document text

<<<PAGE 1>>>

U.S. Department
of Transportation
Pipeline and Hazardous Materials
Safety Administration
Administrator 1200 New Jersey Avenue. SE.
Washington. DC 20590
1:'\' j ~ 6
Aaron Hackman, BA, RT(R) CT
121 EI Dorado Lane
Colorado Springs, CO 80919
Reference No. 11-0261
Dear Mr. Hackman:
This is in response to your October 13, 2011 telephone conversation with a member of my
staff, and October 19, 2011 e-mail requesting clarification of the Hazardous Materials
Regulations (HMR: 49 CFR Parts 171-180) applicable to packagings your company uses
to collect fluid withdrawn from the bodies of patients. You state these fluids typicall y
contain minor amounts of the patient's blood, may meet the definition of a Category B,
Division 6.2 (infectious substance) material, and are described as "UN 3291, Regulated
medical waste, 6.2, PO II," (RMW). You also state a contract carrier supplies your
company with these packagings and transports them for disposal by motor vehicle.
You describe the packagings as being composed of 6 vacuum-sealed glass bottles that
range in size from 250 ml to 1,000 mI, each placed in a fiberboard box and separated by a
6-place divider insert composed of fiberboard. You state two bottles of Vital Care Super
Solidifier absorbent powder are emptied into this box, which is then closed by folding one
corner on each flap at the top of the box under the corner of the adjoining flap. You also
state two of these boxes are placed in a red polyethylene bag that is folded closed and then
secured within a red polyethylene bin that is closed with a lid that snaps shut. In addition,
you state the outer surface of the bin has directional arrows as prescribed § 172.312(a)(2),
and the BIOHAZARD symbol as prescribed in § 172.323(c). You also provide pictures of
the packaging's components. You ask if these packagings comply with § 173 .134( c) of the
HMR.
The answer is no. It is the opinion of this Office that use of both the folded polyethylene
bag and snap shut lid on the polyethylene box would not be effective in preventing the
liquid contents of this packaging from being released if one or more of the inner bottles
were to break. However, this condition may be avoided if the polyethylene bag were
closed in a manner (e.g., twist-tied closed or sealed) that prevented it from releasing its
liquid contents. '
To be excepted from the specification packaging requirements for RMW prescribed in
§ 173.197, the HMR require that the package comply with the requirements prescribed in
§ 173.134(c)(1). These requirements specify that the packaging must be rigid, conform to
the general packaging requirements in §§ 173.24 and 173.24a, and comply with the

<<<PAGE 2>>>

requirements prescribed in 29 CFR 1910.1030 of the Department of Labor, Occupational
Safety and Health Administration's requirements for bloodborne pathogens. Sections
173.24(b)(1) and 173.24(f)(1)(i) require that the packagings and their closures must be
designed and closed so that under transportation conditions normally incident to
transportation, there is no identifiable release of hazardous material to the environment
from the packaging or from the opening to which the closure is applied. Section
173.24(f)(1 )(ii) also requires that the packaging closures must also be leakproof and
secured against loosening. Additionally, the packaging must: 1) be transported by motor
vehicle by a private or contract carrier; 2) not contain any RMW waste cultures or stock;
and 3) display the BIOHAZARD marking in accordance with 29 CFR 1910.1030 to be
excepted from having to display the INFECTIOUS SUBSTANCE label.
I hope this satisfies your request.
Sincerely,
T. Glenn Foster
Chief, Regulatory Review and Reinvention Branch
Standards and Rulemaking Division
cc: Mr. David Linebaugh
Safety Officer
Penrose-Sf. Francis Health Services
2222 North Nevada Avenue
Colorado Springs, CO 80907
2

<<<PAGE 3>>>

Edmonson, Eileen (PHMSA)
From: Hackman, Aaron [AaronHackman@Centura.Org]
Sent: Wednesday, October 19, 2011 6:51 PM
To: Edmonson, Eileen (PHMSA)
Subject: RE: Evacuated Containers
Eileen,
Thank you again for the time spent with me today confirming our compliance with shipping our ascites filled evacuated
containers. I realized you may not have an address to send the official letter to, so I am providing two, if I may. I would
humbly ask that you send a letter to my personal address and work address so that I increase my probability of receiving
at least one of them. ©
Aaron Hackman
Radiology Manager, SFMC
6001 East Woodmen Rd.
Colorado Springs, CO 80923
Home:
Aaron Hackman
121
EI Dorado Lane
Colorado Springs, CO 80919
Sincerely,
Aaron Hackman, BA, RT(R} CT
Manager, Imaging Services
Penrose-St Francis Health Services
719-571-1337
From: eileen.edmonson@dot.gov [mailto:eileen.edmonson@dot.gov]
Sent: Thursday, October 13, 2011 9:22 AM
To: Hackman, Aaron
Subject: My Contact Information
Eileen Edmonson
Transportation Regulations Specialist
Pipeline and Hazardous Material Safety Administration
U.S. Department of Transportation
1200 New Jersey Avenue, SE, PHH-12
Washington, DC 20590
202-366-4481 (w)
202-366-7041 (f)
202-366-3753 (info ctr fax)
http://www.phmsa.dot.gov/hazmat (website)
eileen.edmonson@dot.qov (e-mail)
infocntr@dot.gov (Hazmat Info Center e-mail)
1

## Provenance

- Official: Yes
- Source: <https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretations/2011/110261.pdf>
- Source ID: `phmsa`
- SHA-256: `a37ee8e7e3db5c775d3e0a45addd1dfc3a50aa7cbe5cd33dfcd17b9d819c1e3b`
- Retrieved: 2026-08-20T00:59:31.977Z
- Exported: 2026-08-22T13:57:10.730Z
- Document slug: `phmsa-interpretation-11-0261`

### Source metadata

```json
{
  "materialSubtype": "interpretation",
  "interpretationArea": "hazardous_materials",
  "representation": "full_text_from_official_pdf",
  "companies": [],
  "individuals": [
    "Mr. Aaron Hackman"
  ],
  "refIds": [
    "11-0261"
  ],
  "catalogDates": [
    "2012-01-26"
  ],
  "catalogParts": [
    172,
    173
  ],
  "catalogRowCount": 5,
  "sourceRecordUrls": [
    "https://www.phmsa.dot.gov/node/54256"
  ],
  "linkedAttachmentUrls": [],
  "unavailableResponseUrls": [],
  "duplicateRepresentationUrls": [],
  "citedSections": [
    "172.312",
    "172.312(a)(2)",
    "172.323",
    "172.323(c)",
    "173.134",
    "173.134(c)(1)",
    "173.197",
    "173.24",
    "173.24a"
  ],
  "catalogPageUrls": [
    "https://www.phmsa.dot.gov/regulations/title49/section/172312",
    "https://www.phmsa.dot.gov/regulations/title49/section/172323",
    "https://www.phmsa.dot.gov/regulations/title49/section/173134",
    "https://www.phmsa.dot.gov/regulations/title49/section/173197",
    "https://www.phmsa.dot.gov/regulations/title49/section/17324"
  ],
  "pdfUrls": [
    "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretations/2011/110261.pdf"
  ],
  "representations": [
    {
      "viewUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretations/2011/110261.pdf",
      "detailUrl": null,
      "detailHtmlPath": null,
      "pdfUrl": "https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/legacy/interpretations/Interpretations/2011/110261.pdf",
      "pdfArtifactPath": "data/sources/phmsa-interpretations/11-0261-01c852a851.pdf",
      "pdfArtifactSha256": "fc9e33101e3c4691c213ab7a44e9bb1ac6b6481188c57c2ef780c80de6762355",
      "extractedTextPath": "data/sources/phmsa-interpretations/11-0261-01c852a851.v2.txt",
      "extractedTextSha256": "ecedbe252f40d63cb2d03ebe7a6d1c8a0d029a2666e7e5431510e5b32464a457",
      "pageCount": 3,
      "extractionVersion": 2
    }
  ],
  "caveat": "Interpretations apply regulations to the facts presented and do not create independently enforceable requirements.",
  "jurisdiction": "US"
}
```
